Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). The Advisory Committee on Immunization Practices recommends universal HepB vaccination for adults aged 19-59 years, including pregnant persons, and adults aged ≥60 years with risk factors for hepatitis B. Adults aged ≥60 years without known risk factors for hepatitis B may also receive HepB vaccines (2).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620335 | PMC |
| http://dx.doi.org/10.15585/mmwr.mm7348a3 | DOI Listing |
Publication Analysis
Top Keywords
adults aged
16
vaccination adults
8
aged 19-59
8
19-59 years
8
hepb vaccines
8
aged ≥60
8
≥60 years
8
years risk
8
risk factors
8
factors hepatitis
8
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!